Berridge M V, Okech N
Exp Hematol. 1979 Oct;7(9):452-68.
A model of multiply marked hemopoietic stem cells proposed by Till (1) has been tested with respect to antisera raised against differentiated murine hemopoietic cells. When absorbed with erythrocytes, antisera against CBA mouse lymph node lymphocytes, thymocytes, peritoneal macrophages and platelets cross-reacted strongly with pluripotent stem cells (CFUs) in bone marrow as determined by inhibition of spleen colony formation in lethally irradiated mice. Absorption of ATS, antimacrophage serum and antiplatelet serum with hemopoietic cells other than those used to prepare the antisera (e.g., ATS with neutrophils and platelets, antimacrophage serum with neutrophils, thymocytes and platelets and antiplatelet serum with neutrophils and thymocytes) did not reduce the activity of these antisera for CFUs whereas absorption with the inoculating cell type greatly reduced anti-stem cell activity. Absorption of these antisera with non-hemopoietic tissues such as brain, kidney, liver and testis in general had little effect on antistem cell activity, although a significant loss of activity was observed following absorption of antiplatelet serum with kidney. The antistem cell activity in ATS, antimacrophage serum and antiplatelet serum does not appear to be caused by antibodies against histocompatibility antigens sine bone marrow stem cells from histoincompatible C57BL and Balb/c mice were also sensitive to antisera against CBA mouse hemopoietic cells. In contrast to these findings, antisera against erythrocytes showed little cross-reactivity with CFUs, indicating that few antigens are held in common between erythrocytes and CFUs. We propose that nucleated hemopoietic cells and platelets retain cell line specific antigens in common with pluripotent stem cells from which they were derived, and that the continued expression of these antigens during differentiation may be involved in the differentiation process.
蒂尔(1)提出的多重标记造血干细胞模型,已针对针对分化的小鼠造血细胞产生的抗血清进行了测试。当用红细胞吸收时,针对CBA小鼠淋巴结淋巴细胞、胸腺细胞、腹腔巨噬细胞和血小板的抗血清,与骨髓中的多能干细胞(CFU)发生强烈交叉反应,这是通过在致死性照射小鼠中抑制脾集落形成来确定的。用制备抗血清所用细胞以外的造血细胞吸收抗胸腺细胞血清(ATS)、抗巨噬细胞血清和抗血小板血清(例如,用中性粒细胞和血小板吸收ATS,用中性粒细胞、胸腺细胞和血小板吸收抗巨噬细胞血清,用中性粒细胞和胸腺细胞吸收抗血小板血清),并不会降低这些抗血清对CFU的活性,而用接种细胞类型吸收则会大大降低抗干细胞活性。一般来说,用非造血组织如脑、肾、肝和睾丸吸收这些抗血清,对抗干细胞活性影响不大,尽管在用肾吸收抗血小板血清后观察到活性有显著损失。ATS、抗巨噬细胞血清和抗血小板血清中的抗干细胞活性似乎不是由针对组织相容性抗原的抗体引起的,因为来自组织不相容的C57BL和Balb/c小鼠的骨髓干细胞也对针对CBA小鼠造血细胞的抗血清敏感。与这些发现相反,针对红细胞的抗血清与CFU几乎没有交叉反应,这表明红细胞和CFU之间几乎没有共同的抗原。我们提出,有核造血细胞和血小板与它们所衍生的多能干细胞共同保留细胞系特异性抗原,并且这些抗原在分化过程中的持续表达可能参与了分化过程。